Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
237M
-
Number of holders
-
50
-
Total 13F shares, excl. options
-
25.5M
-
Shares change
-
+9.18M
-
Total reported value, excl. options
-
$115M
-
Value change
-
+$41.3M
-
Number of buys
-
44
-
Number of sells
-
-11
-
Price
-
$4.51
Significant Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q2 2018
59 filings reported holding ADMA - ADMA BIOLOGICS, INC. - COMMON STOCK as of Q2 2018.
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) has 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.5M shares
of 237M outstanding shares and own 10.78% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (6.52M shares), Consonance Capital Management LP (4.25M shares), Aisling Capital LLC (3.61M shares), Broadfin Capital, LLC (3.25M shares), Biomark Capital Management Co. LLC (1.43M shares), VANGUARD GROUP INC (1.13M shares), BlackRock Inc. (971K shares), 683 Capital Management, LLC (885K shares), Stonepine Capital Management, LLC (832K shares), and MORGENS WATERFALL VINTIADIS & CO INC (375K shares).
This table shows the top 50 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.